Vanda Pharmaceuticals Files Q1 2025 10-Q
Ticker: VNDA · Form: 10-Q · Filed: May 8, 2025 · CIK: 1347178
| Field | Detail |
|---|---|
| Company | Vanda Pharmaceuticals Inc. (VNDA) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
Vanda Pharma's Q1 2025 10-Q is in. Financials updated.
AI Summary
Vanda Pharmaceuticals Inc. filed its quarterly report for the period ending March 31, 2025. The filing details financial positions and activities, including changes in common stock and additional paid-in capital during the first quarter of 2025. The company's fiscal year ends on December 31.
Why It Matters
This filing provides investors with an update on Vanda Pharmaceuticals' financial health and operational status for the first quarter of 2025, crucial for assessing the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags or significant new information presented.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-05-08 — Filing Date (The date the report was officially submitted to the SEC.)
Key Players & Entities
- Vanda Pharmaceuticals Inc. (company) — Filer of the 10-Q report
- 20250331 (date) — End of the reporting period
- 20250508 (date) — Filing date of the report
- 2025-01-01 (date) — Start of the reporting period
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the first quarter of 2025, ending on March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q filing was made on May 8, 2025.
What is Vanda Pharmaceuticals Inc.'s fiscal year end?
Vanda Pharmaceuticals Inc.'s fiscal year ends on December 31.
What financial elements are detailed for the first quarter of 2025?
The filing details changes in financial elements such as common stock, additional paid-in capital, retained earnings, and accumulated other comprehensive income for the period from January 1, 2025, to March 31, 2025.
What is the company's SEC file number?
The SEC file number for Vanda Pharmaceuticals Inc. is 001-34186.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Vanda Pharmaceuticals Inc. (VNDA).